Literature DB >> 19870297

BIOCHEMICAL STUDIES ON THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI : I. ISOLATION AND CHARACTERIZATION OF FIBRINOLYSIN.

R L Garner1, W S Tillett.   

Abstract

THE ACTIVE FIBRINOLYTIC PRINCIPLE PRESENT IN CULTURES OF HEMOLYTIC STREPTOCOCCI CAN BE ISOLATED IN STABLE FORM, AND PARTIALLY PURIFIED BY THE FOLLOWING
METHODS: 1. Precipitation of culture filtrate with 3 volumes of 95 per cent ethyl alcohol. 2. Adsorption upon polyaluminum hydroxide B of Willstätter (5) followed by elution with M/10 sodium phosphate buffer, pH 7.3. Concentration can be best accomplished by vacuum dialysis (4) of either culture filtrates or preparations obtained by adsorption and elution. The streptococcal fibrinolysin is characterized by the following properties: 1. It may resist heating to 100 degrees C. for 60 minutes; variations in thermal resistance are described. 2. Partially purified preparations give positive tests for protein. Activity is rapidly and completely destroyed by trypsin or papain. 3. The active principle is demonstrable in dissolved fibrin even after 18 hours incubation.

Entities:  

Year:  1934        PMID: 19870297      PMCID: PMC2132393          DOI: 10.1084/jem.60.2.239

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  4 in total

1.  FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS.

Authors:  W S Tillett; L B Edwards; R L Garner
Journal:  J Clin Invest       Date:  1934-01       Impact factor: 14.808

2.  BIOCHEMICAL STUDIES ON THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI : II. NATURE OF THE REACTION.

Authors:  R L Garner; W S Tillett
Journal:  J Exp Med       Date:  1934-07-31       Impact factor: 14.307

3.  A CONCENTRATING DIALYZER.

Authors:  H S Simms
Journal:  J Exp Med       Date:  1930-01-31       Impact factor: 14.307

4.  THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI.

Authors:  W S Tillett; R L Garner
Journal:  J Exp Med       Date:  1933-09-30       Impact factor: 14.307

  4 in total
  12 in total

1.  IN VITRO LIQUEFACTION OF HUMAN BLOOD CLOTS BY METABOLITES OF BACILLUS SUBTILIS.

Authors:  I R SHIMI; G M IMAN; M W KELADA
Journal:  Arch Mikrobiol       Date:  1963-07-18

2.  Streptokinase; 'streptococcal enzymatic debridement'.

Authors:  S TAYLOR
Journal:  Postgrad Med J       Date:  1950-07       Impact factor: 2.401

Review 3.  Thrombolytic therapy in acute myocardial infarction. A perspective.

Authors:  S Sherry
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  A history of streptokinase use in acute myocardial infarction.

Authors:  Nikhil Sikri; Amit Bardia
Journal:  Tex Heart Inst J       Date:  2007

5.  STREPTOCOCCAL FIBRINOLYSIS: A PROTEOLYTIC REACTION DUE TO A SERUM ENZYME ACTIVATED BY STREPTOCOCCAL FIBRINOLYSIN.

Authors:  L R Christensen
Journal:  J Gen Physiol       Date:  1945-03-20       Impact factor: 4.086

6.  BIOCHEMICAL STUDIES ON THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI : II. NATURE OF THE REACTION.

Authors:  R L Garner; W S Tillett
Journal:  J Exp Med       Date:  1934-07-31       Impact factor: 14.307

7.  Studies on a proteolytic enzyme in human plasma; the relationship between the proteolytic activity of plasma and blood coagulation.

Authors:  O D RATNOFF; R C HARTMANN; C L CONLEY
Journal:  J Exp Med       Date:  1950-02       Impact factor: 14.307

8.  Observations on the release of serum fibrinolysin by specific antigen, peptone, and certain polysaccharides.

Authors:  G UNGAR; S H MIST
Journal:  J Exp Med       Date:  1949-07       Impact factor: 14.307

9.  Proteolytic enzymes; further studies on protein, polypeptide, and other inhibitors of serum proteinase, leucoproteinase, trypsin, and papain.

Authors:  D GROB
Journal:  J Gen Physiol       Date:  1949-11       Impact factor: 4.086

10.  COAGULATION AND LIQUEFACTION OF SEMEN : PROTEOLYTIC ENZYMES AND CITRATE IN PROSTATIC FLUID.

Authors:  C Huggins; W Neal
Journal:  J Exp Med       Date:  1942-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.